TAKEDA PHARMA

Research TAKEDA PHARMA (TKD) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• TickerTKD
• ExchangeHM
• CurrencyEUR
• Financial periodQ4 2025
• RevenueEUR 1.19T
• Net incomeEUR 103.64B
• Free cash flowEUR 150.88B
• Gross margin66.3%